ClinScriptum
Sponsored
Promoted channel
ClinScriptum
@clinscriptum
AI-ассистент для клинической и регуляторной документации
Ad info
Impressions by day
41 active daysClinScriptum
Advertiser: @clinscriptum
Days active: 47Last seen: 1h ago
Mini AppCreative
Проверяем протокол КИ на противоречия: визиты, критерии, дозирование, конечные точки и статистику. Узнайте, как работает ClinScriptum.
- CTA button
- BEITRAG ANZEIGEN
- Reportable
- Yes
Where this ad ran
Top channels by impression count.
Evidence-Based Medicine@evidence_based_medicine · 2,434 members292placements
ФГБУ НЦЭСМП экспертиза ЕАЭС@fgbuexpmed · 6,161 members265placements
NanoBioSmartLab@smart_lab_news257placements
Медицинская терминология и полезные ресурсы для переводчиков, писателей и врачей@mymedpharminfo · 1,026 members131placements
Разработка и Регистрация ЛС | международный фарм.журнал@pharmjournal · 1,607 members126placements
Евразийская экономическая комиссия@eecommission117placements
Uzpharmagency@uzpharm_agency75placements
Uzpharmcontrol@uzpharmcontrol71placements
More from this advertiser · @clinscriptum
Research from the blog
- 2026-09-23
Russia's Telegram Ad Market in 2026 in Numbers: ERIR, Mediascope, CPM and Our Archive
Telegram ad budgets in Russia fell 22% per the official ad register, the audience shrank and CPM dropped 41%, yet placements grew. A short summary of 2026 public figures for the Russian Telegram ad market plus what our archive of 585,000 ads shows.
- 2026-09-23
Telegram Ads in Russia in 2026: the FAS Ban, the Moratorium to 31 December and What to Do Now
Russia's antimonopoly regulator treats advertising in Telegram as illegal but will not penalise it until 31 December 2026. A short guide for international readers: timeline, fines, what the moratorium does not cover and a checklist.